[1]CurrentPatentAssignee:MERCK&COINC-US2003/232863,2003,A1Locationinpatent:Page61
[1]CurrentPatentAssignee:MERCK&COINC-US2003/232863,2003,A1Locationinpatent:Page62
[1]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2006/10264,2006,A1Locationinpatent:Page/Pagecolumn85-86
[1]CurrentPatentAssignee:PFIZERINC-WO2010/116282,2010,A1Locationinpatent:Page/Pagecolumn86-87
[1]CurrentPatentAssignee:SHOUYAOHOLDINGSBEIJINGCOLTD-WO2012/103806,2012,A1Locationinpatent:Page/Pagecolumn31-32
Title: Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.
Journal: Nature chemical biology 20110413